Prof Braconi is a research-active consultant medical oncologist with a wide expertise in tumours of the bile duct, liver and pancreas.

She brings a globally diverse skillset having completed her professional training across multiple countries in Europe and America. She received her medical doctor degree from the Polytechnic University of Marche in Italy, and completed her fellowship in Medical Oncology in 2006, after training between the University Hospital in Ancona, Italy and the Queen Elizabeth Hospital in Birmingham, UK. She achieved a PhD in oncology in 2009 with studies on liver cancers and new therapeutic strategies. After 5 years at The Ohio State University (USA), she joined the University of Glasgow in 2012 with a Chief Scientist Office Fellowship through which she expanded her academic achievements and core competences by dedicating her time to both clinical management of cancer patients and research work. She worked as medical oncologist at the Royal Marsden Hospital between 2014 and 2019, focussing on tumours of the bile ducts, liver and pancreas.

She returned to Scotland in 2019 with a Lord Kelvin Adam Smith fellowship, to join the University of Glasgow where she currently holds a Professorship as Chair of HepatoBilary Oncology. At the Beatson Cancer Centre she has been the leader of the West of Scotland bile duct cancer clinic, looking after patients receiving systemic anticancer therapy, such as chemotherapy, targeted therapies and immunotherapy. She has been involved in setting up and conducting large academic and translational studies and acts as chief investigator and principal investigator of multiple international clinical trials. Throughout her career she has been interested is delivering a programme of precision oncology and has engaged with academics, industry partners and policy makers to provide patients access to an individualized approach.

She is internationally recognised in her field; she is co-chair of the European consortium Precision-Biliary Tract Cancer network and she is actively involved in writing national and international clinical guidelines for the management of patients.

She is Clinical Lead of the Scottish Bile Duct Clinical Management Pathways for systemic therapies and acts as clinical expert adviser for the Scottish Medicine Consortium and the National Institute for Health and Care Excellence.

Prof Braconi is also active in teaching and mentoring at national and international level, she has extensively published her research on liver, bile duct and pancreatic cancer in high impact journals (Lancet Oncology, Science, Nature Communication amongst others) and is actively participating in international conferences as speaker, chair and organizer. 

Clinical Interests

• Bile duct Cancers
• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular carcinoma
• Pancreatic Cancer
• Liver Cancer

• Royal College of Physicians
• European Network for the Study of Cholangiocarcinoma (ENSCCA)